Concepedia

Author

Alain Schotte

Janssen (Belgium)

Also Known As

A SCHOTTE, A Schotte, A. SCHOTTE, A. Schotte, A.G. Schotte, Alain Schotte, Schotte, Alain

51

Publications

3.7K

Citations

23

H-Index

41

Concepts

All Affiliations

Janssen (Belgium)Vrije Universiteit AmsterdamHôpital Saint-AntoineSorbonne UniversitéAmsterdam Neuroscience
AS

About

Alain Schotte is an author at Janssen (Belgium) specializing in medicine, neuroscience, and neuropharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

18

21

2.8K

2

Social Sciences

13

15

941

3

Neurology

5

5

489

4

Health Sciences

1

1

164

5

Anesthesia

1

1

47

Alain Schotte

×

29

Publications

3.5K

Citations

23

H-Index

YearCitations

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

Alain Schotte, Paul Janssen, W Gommeren,

Psychopharmacology

1996

1.2K

Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors

J E Leysen, Paul M. F. Janssen, Alain Schotte,

Psychopharmacology

1993

335

Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography

Alain Schotte, P.F.M. Janssen, Anton A. H. P. Megens,

Brain Research

1993

225

Efficacy and Safety of the 3-Month Formulation of Paliperidone Palmitate vs Placebo for Relapse Prevention of Schizophrenia

Joris Berwaerts, Yanning Liu, Srihari Gopal,

JAMA Psychiatry

2015

193

Evidence for a displaceable non-specific [3H]neurotensin binding site in rat brain

Alain Schotte, J.E. Leysen, Pierre M. Laduron

Naunyn-Schmiedeberg s Archives of Pharmacology

1986

164

Efficacy and Safety of Paliperidone Palmitate 3-Month Formulation for Patients with Schizophrenia: A Randomized, Multicenter, Double-Blind, Noninferiority Study

Adam Savitz, Haiyan Xu, Srihari Gopal,

The International Journal of Neuropsychopharmacology

2016

159

Two populations of neurotensin binding sites in murine brain: discrimination by the antihistamine levocabastine reveals markedly different radioautographic distribution

Patrick Kitabgi, William Rostène, Monique Dussaillant,

European Journal of Pharmacology

1987

133

Characterization and regional distribution of serotonin S2-receptors in human brain

Alain Schotte, J.M. Maloteaux, Pierre M. Laduron

Brain Research

1983

132

Detailed mapping of serotonin 5-HT1B and 5-HT1D receptor messenger RNA and ligand binding sites in guinea-pig brain and trigeminal ganglion: clues for function

Pascal Bonaventure, Pieter Voorn, Walter Luyten,

Neuroscience

1997

120

Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.

J.E. Leysen, W Gommeren, Lieve Heylen,

Molecular Pharmacology

1996

91

Page 1